Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Clinical trial NCT04001621 · UNKNOWN
Trial details
- NCT number
- NCT04001621
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2023-05-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.